Summary & Overview
CPT 16028: Skin Graft Procedure
CPT code 16028 denotes a skin graft procedure used for wound or soft-tissue coverage. It is a nationally recognized procedural code in the Current Procedural Terminology (CPT) system and is relevant to surgical, dermatologic, and reconstructive practices. Accurate coding of 16028 affects billing, clinical documentation, and claims processing across major payers.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and typical care settings, along with national payer coverage considerations and common benchmarking topics relevant to reimbursement and utilization. The publication outlines what providers and billing professionals need to know about service classification, expected sites of service, and where to look for payer-specific policies.
The content covers clinical context for the procedure, common documentation elements tied to skin grafting services, and areas where policy updates or payer guidance commonly appear. Data not available in the input is noted where necessary. This summary is intended for a national audience of clinicians, coding professionals, and healthcare administrators seeking a clear, policy-focused briefing on CPT code 16028.
Billing Code Overview
CPT code 16028 represents a procedure described as 16028. The code corresponds to a skin grafting service involving wound or soft-tissue coverage consistent with the brief description provided.
-
Service type: Skin graft procedure
-
Typical site of service: Ambulatory surgical center or hospital operating room
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric individual presenting to an outpatient dermatology or general surgery clinic with one or more benign epidermal lesions (eg, warts, molluscum contagiosum, benign keratoses) or selected small cutaneous neoplasms for which a chemical destruction method is appropriate. The provider evaluates lesion(s), documents size, location, number, prior treatments, and patient consent for topical chemical destruction. The clinician prepares the site, applies the appropriate chemical agent (commonly liquid nitrogen cryotherapy or podophyllin/ trichloroacetic acid depending on the lesion and coding context), monitors the reaction, provides wound care instructions, and schedules follow-up for healing and assessment. Typical site of service is an outpatient clinic, dermatology office, or ambulatory surgery center for larger or multiple lesions requiring extended application time. The procedure is brief, often completed during the same visit, and may be billed per lesion depending on the agent and CPT guidance for code 16028.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is performed and documented in addition to the procedure |